EUVIMEDEUVIMED entdecken
Klinische Studie

Halobetasol Propionate/Tazarotene Lotion for Scalp Psoriasis: Efficacy in Itch Reduction, Disease Clearance, and Hair Appearance

Zoe Draelos, Abby Jacobson

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.8841 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Zoe Draelos und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Clobetasol, Psoriasis, Nicotinic Acids, Pruritus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClobetasolPsoriasisNicotinic AcidsPruritusScalp DermatosesDermatologic AgentsHairHumansMaleFemaleMiddle AgedAdultTreatment OutcomeDrug CombinationsSeverity of Illness IndexScalpSkin CreamAgedAdministration, CutaneousYoung AdultRetinoids

Substanzen

ClobetasolNicotinic AcidsDrug CombinationsDermatologic AgentstazaroteneRetinoidshalobetasol

Zitieren

APA

Draelos, Z., & Jacobson, A. (2025). Halobetasol Propionate/Tazarotene Lotion for Scalp Psoriasis: Efficacy in Itch Reduction, Disease Clearance, and Hair Appearance. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8841

Vancouver

Draelos Z, Jacobson A. Halobetasol Propionate/Tazarotene Lotion for Scalp Psoriasis: Efficacy in Itch Reduction, Disease Clearance, and Hair Appearance. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8841

BibTeX
@article{Draelos2025,
  author = {Draelos, Zoe and Jacobson, Abby},
  title = {Halobetasol Propionate/Tazarotene Lotion for Scalp Psoriasis: Efficacy in Itch Reduction, Disease Clearance, and Hair Appearance},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.8841}
}
Kostenlos starten →